Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Klotho Neurosciences, Inc. (GRML) had Non-Operating Income/Expense of $1.81M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.69M |
|
-- |
|
-- |
|
$5.49M |
|
$-5.49M |
|
|
Non-Operating Income/Expense |
$1.81M |
$-3.69M |
|
$-3.69M |
|
$-3.69M |
|
$-3.69M |
|
$-3.69M |
|
$-3.69M |
|
$-5.49M |
|
$-5.49M |
|
2.53M |
|
2.53M |
|
$-1.50 |
|
$-1.50 |
|
| Balance Sheet Financials | |
$12.21M |
|
-- |
|
$52.81M |
|
$65.01M |
|
$1.21M |
|
-- |
|
$5.90M |
|
$7.11M |
|
$57.90M |
|
$9.23M |
|
$57.90M |
|
3.18M |
|
| Cash Flow Statement Financials | |
$-11.82M |
|
$-0.79M |
|
$14.79M |
|
$7.18M |
|
$9.34M |
|
$2.17M |
|
$5.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.09 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.14M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.36% |
|
-39.91% |
|
-5.67% |
|
-6.36% |
|
$18.23 |
|
$-4.80 |
|
$-4.67 |
|